azd5305
Showing 1 - 7 of 7
Prostate Cancer Trial in Worldwide (AZD5305, Darolutamide, No Treatment)
Not yet recruiting
- Prostate Cancer
- AZD5305
- +2 more
-
Melbourne, Australia
- +7 more
Jul 3, 2023
Metastatic Prostate Cancer Trial in Australia, United Kingdom (AZD5305, Enzalutamide, Abiraterone Acetate)
Recruiting
- Metastatic Prostate Cancer
- AZD5305
- +3 more
-
San Diego, California
- +25 more
Jan 10, 2023
Ovarian Cancer, Lung Adenocarcinoma Trial in United States (AZD5335, AZD5305)
Not yet recruiting
- Ovarian Cancer
- Lung Adenocarcinoma
- AZD5335
- AZD5305
-
Duarte, California
- +6 more
Mar 21, 2023
Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)
Recruiting
- Ovarian Cancer
- +12 more
- AZD5305
- +4 more
-
San Francisco, California
- +44 more
Jul 12, 2022
Metastatic Castration-Sensitive Prostate Cancer Trial in Worldwide (AZD5305, Placebo, Abiraterone Acetate)
Not yet recruiting
- Metastatic Castration-Sensitive Prostate Cancer
- AZD5305
- +4 more
-
Tucson, Arizona
- +192 more
Nov 6, 2023
Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan
Not yet recruiting
- Endometrial Cancer
- +4 more
- Datopotamab deruxtecan (Dato-DXd)
- +8 more
-
Los Angeles, California
- +52 more
Aug 3, 2022